CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--Emisphere Technologies, Inc. (OTC BB: EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules using its Eligen® Technology, today announced that President and Chief Executive Officer, Michael V. Novinski, will present at the 12th Annual BIO CEO & Investor Conference at 2:30 PM EST on Tuesday, February 9, 2010. The BIO CEO Conference is being held at the Waldorf-Astoria Hotel in New York City.
